Currently, there are 2.75B common shares owned by the public and among those 1.60B shares have been available to trade.
The company’s stock has a 5-day price change of 3.66% and 11.77% over the past three months. ORCL shares are trading 32.00% year to date (YTD), with the 12-month market performance up to 19.50% higher. It has a 12-month low price of $99.26 and touched a high of $146.59 over the same period. ORCL has an average intraday trading volume of 8.50 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.06%, 0.92%, and 15.11% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Oracle Corp. (NYSE: ORCL) shares accounts for 44.96% of the company’s 2.75B shares outstanding.
It has a market capitalization of $383.53B and a beta (3y monthly) value of 1.00. The stock’s trailing 12-month PE ratio is 37.55, while the earnings-per-share (ttm) stands at $3.71. The company has a PEG of 3.54 and a Quick Ratio of 0.70 with the debt-to-equity ratio at 10.85. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.23% over the week and 2.01% over the month.
Earnings per share for the fiscal year are expected to increase by 12.50%, and 14.97% over the next financial year. EPS should grow at an annualized rate of 10.61% over the next five years, compared to 4.54% over the past 5-year period.
Looking at the support for the ORCL, a number of firms have released research notes about the stock. BMO Capital Markets stated their Market Perform rating for the stock in a research note on June 17, 2024, with the firm’s price target at $142-$160. William Blair on their part issued Outperform rating on March 12, 2024.
